Delivery Order SPE2DB20D1109-SPE2DB25FP82M
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,659.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on September 11, 2025, with completion targeted for September 12, 2025. This non-competitive, non-set-aside award represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.84 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count package), with an ultimate completion date of August 13, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $8,258.16 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be completed by August 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,233.81 to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count packaging) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $9,217.95. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $5,153.60 to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the pharmaceutical supply chain support that...
- The Defense Logistics Agency awarded a delivery order valued at $5,506.30 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units. This contract, awarded on August 12, 2025, with completion scheduled for August 13, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- The Defense Logistics Agency awarded a delivery order valued at $212,889.17 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 500 units. This firm fixed price, competitively awarded delivery order is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the vendor competed against other qualified...
- The Defense Logistics Agency awarded a delivery order valued at $1,834.54 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count packaging) on August 15, 2025, with completion expected by August 18, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,255.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement requirements. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...